Donepezil is a valuable treatment option not just for its capacity as a selective inhibitor of acetylcholinesterase for the patients but also for its capacity to ease the burden of the caregiver by prolonging the AD patient's ability to perform self-care tasks and delaying the progression of symptoms that would impact a caregiver [5]. Here, ACHE is linked to Alzheimer disease.